Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

PepGen Inc. (PEPG)

$2.52 -6.67% NASDAQ: PEPG · 15-min delayed
  • BOSTON, Massachusetts
  • Public · NASDAQ: PEPG
  • 59 employees
$133.5MMarket cap
-$89.7MNet income
59Employees
PEPGNASDAQ
2022IPO

About PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Net income
-$89.7M
Total assets
$173.9M
Market cap
$133.5M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: PEPG
$2.52 -6.67%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.35 $7.17

52-week range

Market cap
$133.5M
Shares outstanding
53.0M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
May 6, 2022

PepGen Inc. (PEPG) Stock Price

  • Reported a net loss of $89.7M.
  • Trading 65% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review PepGen Inc..

Write a review
Newsroom

News about PepGen Inc.

News & sentiment via Polygon.io

FAQ

PepGen Inc.: frequently asked questions

Is PepGen Inc. an American company?

PepGen Inc. is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is PepGen Inc. headquartered?

PepGen Inc. is headquartered in Boston, Massachusetts, United States.

Is PepGen Inc. publicly traded?

Yes — PepGen Inc. is a publicly traded company. Its stock trades under the ticker symbol PEPG on the NASDAQ.

What does PepGen Inc. do?

PepGen Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →